Comparison of Enoxaparin and Warfarin for Secondary Prevention of Cancer-Associated Stroke

Table 4

Multiple logistic regression analysis: independent predictors of D-dimer levels ≥10 μg/mL.

	Estimated OR
	Univariable	Multivariable
	(95% CI^†)	(95% CI)
Treatment
Enoxaparin	Reference	Reference
Warfarin	6.72 (1.92–23.58)	12.95 (2.89–57.94)	0.001
Systemic metastasis	6.96; (0.80–60.53)	18.73; (1.69–207.48)	0.017
Adenocarcinoma	3.58 (0.86–14.87)	2.41 (0.43–13.44)	0.314

OR: odds ratio; ^†CI: confidence interval.